title: Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive.
abstract: Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, extends the life span of yeast, worms, flies, and mice. Interventions that promote longevity are often correlated with increased insulin sensitivity, and it therefore is surprising that chronic rapamycin treatment of mice, rats, and humans is associated with insulin resistance (J Am Soc Nephrol., 19, 2008, 1411; Diabetes, 00, 2010, 00; Science, 335, 2012, 1638). We examined the effect of dietary rapamycin treatment on glucose homeostasis and insulin resistance in the genetically heterogeneous HET3 mouse strain, a strain in which dietary rapamycin robustly extends mean and maximum life span. We find that rapamycin treatment leads to glucose intolerance in both young and old HET3 mice, but in contrast to the previously reported effect of injected rapamycin in C57BL/6 mice, HET3 mice treated with dietary rapamycin responded normally in an insulin tolerance test. To gauge the overall consequences of rapamycin treatment on average blood glucose levels, we measured HBA1c. Dietary rapamycin increased HBA1c over the first 3 weeks of treatment in young animals, but the effect was lost by 3 months, and no effect was detected in older animals. Our results demonstrate that the extended life span of HET3 mice on a rapamycin diet occurs in the absence of major changes in insulin sensitivity and highlight the importance of strain background and delivery method in testing effects of longevity interventions.
authors: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
authors: Dudley W
authors: DW
authors: Lamming
authors: Lan
authors: L
authors: Ye
authors: Clinton M
authors: CM
authors: Astle
authors: Joseph A
authors: JA
authors: Baur
authors: David M
authors: DM
authors: Sabatini
authors: David E
authors: DE
authors: Harrison
mesh_terms: D000367:Age Factors; D000818:Animals; D001786:Blood Glucose; D004032:Diet; D005260:Female; D018740:Genetic Heterogeneity; D005838:Genotype; D005947:Glucose / Q000378:metabolism; D018149:Glucose Intolerance; D006442:Glycated Hemoglobin / Q000032:analysis; D007333:Insulin Resistance; D008136:Longevity; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D019289:Pyruvic Acid / Q000378:metabolism; D020123:Sirolimus / Q000008:administration & dosage* / Q000494:pharmacology; D013045:Species Specificity
chemical_list: D001786:Blood Glucose; D005947:Glucose; D006442:Glycated Hemoglobin; D019289:Pyruvic Acid; D020123:Sirolimus
keywords: aging; glucose tolerance; heterogeneous mice; insulin tolerance; rapamycin
references: Diabetes. 2010 Jun;59(6):1338-48
references: 20299475
references: J Gerontol A Biol Sci Med Sci. 2011 Feb;66(2):191-201
references: 20974732
references: FASEB J. 2008 Mar;22(3):807-18
references: 17928362
references: Cell Metab. 2012 Apr 4;15(4):505-17
references: 22482732
references: J Am Soc Nephrol. 2005 Oct;16(10):3128-35
references: 16107580
references: J Mol Med (Berl). 2012 May;90(5):575-85
references: 22105852
references: J Endocrinol. 2002 Apr;173(1):81-94
references: 11927387
references: J Gerontol A Biol Sci Med Sci. 2013 Feb;68(2):108-16
references: 22570137
references: Diabetes Care. 1998 Dec;21(12):2191-2
references: 9839117
references: Sci Signal. 2009 Nov 24;2(98):ra75
references: 19934433
references: J Am Soc Nephrol. 2008 Jul;19(7):1411-8
references: 18385422
references: Diabetes Care. 2003 Mar;26(3):917-32
references: 12610059
references: Nature. 2009 Jul 16;460(7253):392-5
references: 19587680
references: J Gerontol A Biol Sci Med Sci. 2010 Dec;65(12):1275-84
references: 20819793
references: Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E398-9
references: 19171846
references: Nature. 2006 Nov 16;444(7117):337-42
references: 17086191
references: Nature. 2007 Nov 29;450(7170):736-40
references: 18046414
references: Science. 2009 Oct 2;326(5949):140-4
references: 19797661
references: Mol Cell. 2006 Apr 21;22(2):159-68
references: 16603397
references: EMBO Mol Med. 2013 Apr;5(4):563-71
references: 23483710
references: Diabetes Care. 2004 Jun;27(6):1487-95
references: 15161807
references: Science. 2012 Mar 30;335(6076):1638-43
references: 22461615